FUJIFILM Holdings Corporation / FUJIFILM Corporation

FUJIFILM is no longer simply “a company that sells film and cameras.” It is an integrated precision-chemistry and life-science group that successfully transferred the precision chemistry, film-coating, nanotechnology, collagen, and antioxidant capabilities developed through photographic film into healthcare, including medical imaging equipment, Bio CDMO contract manufacturing, ASTALIFT cosmetics, and pharmaceuticals; high-performance materials, including semiconductor EUV photoresists and display materials; office imaging, including the former Fuji Xerox multifunction-printer business now operated as Business Innovation; and the remaining imaging business, including instax “Cheki” instant cameras and X Series cameras. Consolidated revenue for the fiscal year ended March 2025 was approximately ¥3.1958 trillion, and Healthcare has become the largest growth engine, with revenue exceeding ¥1 trillion and accounting for roughly 84% of group capital expenditure.